What Oncologists Need to Know about Biosimilars
Dr. Gary Lyman, MPH, FASCO, FRCP, joins ASCO CEO Dr. Clifford A. Hudis to discuss biosimilars and ASCO's recent statement on biosimilars published in the Journal of Clinical Oncology.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of ASCO in Action Podcast?
This episode is 25 minutes long.
When was this ASCO in Action Podcast episode published?
This episode was published on May 15, 2018.
Can I download this ASCO in Action Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.